The study investigated patients using Orthofix’s SpinalStim bone growth therapy device experienced less pain as well as increased function and quality of life, according to a Dec. 21 news release from Orthofix.
Conducted at 10 centers in the U.S., the study included a total of 142 patients with one or more risk factors for pseudarthrosis. The patients used SpinalStim for six months after the procedure and over 82 percent experienced a successful fusion.
The study was published in the International Journal of Spine Surgery, the release said.
